These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2353140)

  • 1. [Reversible cardiogenic shock due to 5FU. Apropos of a case report].
    Dieudonne P; Dumont MA
    Rev Med Brux; 1990 May; 11(5):162-6. PubMed ID: 2353140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reversible cardiogenic shock under 5-fluorouracil treatment].
    Bakouboula B; Morel O; Douchet MP; Chauvin M
    Ann Cardiol Angeiol (Paris); 2005 Aug; 54(4):216-9. PubMed ID: 16104623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capecitabine caused cardiogenic shock through induction of global Takotsubo syndrome.
    Y-Hassan S; Tornvall P; Törnerud M; Henareh L
    Cardiovasc Revasc Med; 2013; 14(1):57-61. PubMed ID: 23218901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiogenic shock caused by 5-fluorouracil].
    Mazet C; Dellinger A; Vital Durand D; Adnaoui M; Fournier G; Levrat R
    Ann Cardiol Angeiol (Paris); 1990 Mar; 39(3):179-80. PubMed ID: 2344152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of cardiogenic shock caused by capecitabine treatment.
    To AC; Looi KL; Damianovich D; Taylor GB; Sidebotham D; White HD
    Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):725-9. PubMed ID: 18813211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiotoxicity of continuous intravenous infusion of 5-fluorouracil: clinical study, prevention and physiopathology. Apropos of 13 cases].
    de Forni M; Bugat R; Sorbette F; Delay M; Bachaud JM; Chevreau C
    Bull Cancer; 1990; 77(5):429-38. PubMed ID: 2205312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of gastric cancer with Borrmann type 4 responding to 5-FU-MMC combined chemotherapy].
    Hirama K; Mikami Y; Nishi T; Suzuki H; Sugiyama Y; Konn M
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2497-9. PubMed ID: 7944497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible cardiogenic shock following 5-fluorouracil infusion.
    Ferté C; Gomez Roca C; Loriot Y; Bahleda R; Moldovan C; Cohen A; Izzedine H; Soria JC; Ederhy S
    Invest New Drugs; 2010 Aug; 28(4):531-3. PubMed ID: 19499187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of advanced gastric cancer responding to combination chemotherapy with low-dose 5-FU plus CDDP].
    Ishio T; Kohnoe S; Endo K; Yamamoto M; Ikeda Y; Toh Y; Baba H; Okamura T; Kawamoto K
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1627-30. PubMed ID: 12355950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cisplatin-fluorouracil chemotherapy in epidermoid cancers of glottic origin staged as T2].
    Laccourreye O; Bassot V; Naudo P; Jouffre V; Brasnu D; Laccourreye H
    Ann Otolaryngol Chir Cervicofac; 1994; 111(5):281-91. PubMed ID: 7755306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case report: postoperative recurrence of peritoneal dissemination of gastric cancer responding to sequential methotrexate and 5-FU (5-fluorouracil)].
    Mizumoto K; Sawada T; Furumoto T; Kawamura Y; Kishi K; Katoh K
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):281-4. PubMed ID: 7857105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of oxaliplatin on 5-fluorouracil plasma clearance and clinical consequences.
    Boisdron-Celle M; Craipeau C; Brienza S; Delva R; Guérin-Meyer V; Cvitkovic E; Gamelin E
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):235-43. PubMed ID: 11935216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiac toxicity of fluoro-uracil. Typical and atypical aspects. Apropos of 8 cases].
    Ferrari E; Taillan B; Tibi T; Darmon JP; Gibelin P; Chichmanian RM; Dujardin P; Morand P
    Ann Cardiol Angeiol (Paris); 1992 Apr; 41(4):191-5. PubMed ID: 1642435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of primary orbital adenocarcinoma responding to chemoradiation].
    Fukui T; Yoshioka T; Takano J; Fujishima S; Otake S; Orii T; Sato T; Sasaki Y; Nishise S; Takeda H; Kawata S; Takamura H
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):287-90. PubMed ID: 19223747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of patients with persistent chest pain and ST-segment elevation during 5-fluorouracil treatment: report about two cases.
    Mafrici A; Alberti A; Corrada E; Ferrari S; Marenna B
    Ital Heart J; 2003 Dec; 4(12):895-9. PubMed ID: 14976858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin combined with continuous infusion of 5-fluorouracil as first-line chemotherapy in patients with metastatic or recurrent gastric adenocarcinoma.
    Lim JY; Cho JY; Oh KJ; Choi SH; Lee SI; Jeung HC
    Chemotherapy; 2009; 55(4):200-6. PubMed ID: 19451710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of advanced colon cancer responding to l-LV+5-FU as neoadjuvant chemotherapy].
    Ishiyama T; Nakamura T; Suzuki T; Inazawa K
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1097-9. PubMed ID: 15272593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Induction chemotherapy in cancer of the upper respiratory and digestive tract. Preliminary results of the protocol combining cisplatin, 5-fluorouracil and bleomycin (CFB)].
    Laccourreye H; Bassot V; Lacau St Guily J; Brasnu D; Menard M; Donnadieu S; Jacquillat C
    Ann Otolaryngol Chir Cervicofac; 1985; 102(1):1-6. PubMed ID: 2408533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma.
    Chung YS; Yamashita Y; Inoue T; Matsuoka T; Nakata B; Onoda N; Maeda K; Sawada T; Kato Y; Shirasaka T; Sowa M
    Cancer; 1997 Jul; 80(1):1-7. PubMed ID: 9210702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.